Frontier Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.9M | Sell |
|
|||||
|
2025
Q2 | $57.1M | Sell |
|
|||||
|
2025
Q1 | $96.7M | Buy |
|
|||||
|
2024
Q4 | $86M | Buy |
|
|||||
|
2024
Q3 | $64.2M | Buy |
|
|||||
|
2024
Q2 | $12M | Buy |
|
|||||
|
2024
Q1 | $7.59M | Sell |
|
|||||
|
2023
Q4 | $7.43M | Buy |
|
|||||
|
2023
Q3 | $7.63M | Sell |
|
|||||
|
2023
Q2 | $7.79M | Sell |
|
|||||
|
2023
Q1 | $13.7M | Sell |
|
|||||
|
2022
Q4 | $63.1M | Buy |
|
|||||
|
2022
Q3 | $39.2M | Sell |
|
|||||
|
2022
Q2 | $50.1M | Buy |
|
|||||
|
2022
Q1 | $32.2M | Sell |
|
|||||
|
2021
Q4 | $42.4M | Buy |
|
|||||
|
2021
Q3 | $16.1M | Sell |
|
|||||
|
2021
Q2 | $19.7M | Sell |
|
|||||
|
2021
Q1 | $21.5M | Buy |
|
|||||
|
2020
Q4 | $4.42M | Sell |
|
|||||
|
2020
Q3 | $3.31M | Sell |
|
|||||
|
2020
Q2 | $5.54M | Buy |
|
|||||
|
2020
Q1 | $3.76M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $20M | Buy |
|
|||||
|
2016
Q3 | $7.43M | Sell |
|
|||||
|
2016
Q2 | $7.3M | Buy |
|
|||||
|
2016
Q1 | $4.28M | Sell |
|
|||||
|
2015
Q4 | $7.55M | Buy |
|
|||||
|
2015
Q3 | $3.25M | Sell |
|
|||||
|
2015
Q2 | $20.9M | Sell |
|
|||||
|
2015
Q1 | $35.8M | Buy |
|
|||||
|
2014
Q4 | $22.4M | Buy |
|
|||||
|
2014
Q3 | $16M | Sell |
|
|||||
|
2014
Q2 | $21M | Sell |
|
|||||
|
2014
Q1 | $40.5M | Buy |
|
|||||
|
2013
Q4 | $26.9M | Sell |
|
|||||
|
2013
Q3 | $62.3M | Sell |
|
|||||
|
2013
Q2 | $52.3M | Buy |
|